HARTFORD, Conn. (WTNH)– Hartford HealthCare has been involved in a lot of research when it comes to COVID-19. Rocco Orlando, MD, Chief of Academic Affairs, at Hartford HealthCare, talks to News 8 about their findings.
Hartford Healthcare has a long history of medical research. During the COVID-19 pandemic, they formed a leadership group within their research organization and created a database just to analyze COVID-19 information.
One development: they have developed antibodies in a lab, and will begin phase one clinical trials using them soon.
Dr. Orlando explained, “There’s a great deal of promise for that targeted approach and it’s really very similar to the convalescent plasma infusion where, again, you’re relying on antibody that has developed in a patient who has had the disease.”
Doctor Orlando says the analytics process has led researchers to some older drugs that could have potential in treated COVID-19.
Research is being done on drugs for conditions including rheumatoid arthritis and stomach acid. And with their relationship with MIT now bolstered on many levels, yet another goal for which to strive:
“We’re also working with the MIT team to create a new – and we hope simpler – way to make the diagnosis of COVID 19,” Dr. Orlando said, “using some different technology than what has generally been applied.”
That lab-made antibody trials are weeks from starting and Hartford Healthcare already has a number of clinical trials underway with some pharmaceutical companies.
WEB EXTRA: Full interview with Rocco Orlando, MD, Chief of Academic Affairs, at Hartford HealthCare.
Every day that goes by during this pandemic, cases of cancer are missed being diagnosed because people are not getting their proper screenings.
Doctor Jeffry Nestler, Chief of Gastroenterology at Hartford Hospital, tells us about that and safety protocols in place in hospital units and ambulatory surgery centers in the video below.